NCOA3 and breast cancer: PFKFB4 is reported to be a robust stimulator to nuclear receptor coactivator 3 (NCOA3) which drives glucose flux towards the PPP and up-regulates the activity of estrogen receptor to further promote aggressiveness of breast cancer [14].